Logo image of ICCM

ICECURE MEDICAL LTD (ICCM) Stock Overview

NASDAQ:ICCM - IL0011224156 - Common Stock

1.19 USD
+0.2 (+20.8%)
Last: 8/28/2025, 7:50:01 PM
1.19 USD
0 (0%)
After Hours: 8/28/2025, 7:50:01 PM

ICCM Key Statistics, Chart & Performance

Key Statistics
52 Week High1.66
52 Week Low0.48
Market Cap81.69M
Shares68.65M
Float40.78M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.28
PEN/A
Fwd PEN/A
Earnings (Next)11-03 2025-11-03
IPO02-02 2011-02-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ICCM short term performance overview.The bars show the price performance of ICCM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30 40

ICCM long term performance overview.The bars show the price performance of ICCM in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60 80

The current stock price of ICCM is 1.19 USD. In the past month the price increased by 16.67%. In the past year, price increased by 85.44%.

ICECURE MEDICAL LTD / ICCM Daily stock chart

ICCM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.81 228.64B
ISRG INTUITIVE SURGICAL INC 58.86 169.86B
BSX BOSTON SCIENTIFIC CORP 37.37 156.70B
SYK STRYKER CORP 30.32 148.97B
MDT MEDTRONIC PLC 16.63 117.82B
BDX BECTON DICKINSON AND CO 13.4 54.82B
IDXX IDEXX LABORATORIES INC 53.87 51.76B
EW EDWARDS LIFESCIENCES CORP 31.61 47.69B
RMD RESMED INC 28.84 40.32B
GEHC GE HEALTHCARE TECHNOLOGY 15.82 33.66B
DXCM DEXCOM INC 44.16 29.44B
PHG KONINKLIJKE PHILIPS NVR- NY 16.51 26.56B

About ICCM

Company Profile

ICCM logo image IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

Company Info

ICECURE MEDICAL LTD

7 Ha'eshel St., PO Box 3163

CAESAREA IL

CEO: EYAL SHAMIR

Employees: 65

ICCM Company Website

ICCM Investor Relations

Phone: 97246230333

ICECURE MEDICAL LTD / ICCM FAQ

What is the stock price of ICECURE MEDICAL LTD today?

The current stock price of ICCM is 1.19 USD. The price increased by 20.8% in the last trading session.


What is the ticker symbol for ICECURE MEDICAL LTD stock?

The exchange symbol of ICECURE MEDICAL LTD is ICCM and it is listed on the Nasdaq exchange.


On which exchange is ICCM stock listed?

ICCM stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ICECURE MEDICAL LTD stock?

9 analysts have analysed ICCM and the average price target is 2.64 USD. This implies a price increase of 122% is expected in the next year compared to the current price of 1.19. Check the ICECURE MEDICAL LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ICECURE MEDICAL LTD worth?

ICECURE MEDICAL LTD (ICCM) has a market capitalization of 81.69M USD. This makes ICCM a Micro Cap stock.


How many employees does ICECURE MEDICAL LTD have?

ICECURE MEDICAL LTD (ICCM) currently has 65 employees.


What are the support and resistance levels for ICECURE MEDICAL LTD (ICCM) stock?

ICECURE MEDICAL LTD (ICCM) has a support level at 0.85 and a resistance level at 1.2. Check the full technical report for a detailed analysis of ICCM support and resistance levels.


Is ICECURE MEDICAL LTD (ICCM) expected to grow?

The Revenue of ICECURE MEDICAL LTD (ICCM) is expected to grow by 50.15% in the next year. Check the estimates tab for more information on the ICCM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ICECURE MEDICAL LTD (ICCM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ICECURE MEDICAL LTD (ICCM) stock pay dividends?

ICCM does not pay a dividend.


When does ICECURE MEDICAL LTD (ICCM) report earnings?

ICECURE MEDICAL LTD (ICCM) will report earnings on 2025-11-03.


What is the Price/Earnings (PE) ratio of ICECURE MEDICAL LTD (ICCM)?

ICECURE MEDICAL LTD (ICCM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).


What is the Short Interest ratio of ICECURE MEDICAL LTD (ICCM) stock?

The outstanding short interest for ICECURE MEDICAL LTD (ICCM) is 4.35% of its float. Check the ownership tab for more information on the ICCM short interest.


ICCM Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ICCM. When comparing the yearly performance of all stocks, ICCM is one of the better performing stocks in the market, outperforming 91.7% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ICCM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ICCM. ICCM has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ICCM Financial Highlights

Over the last trailing twelve months ICCM reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 4.11% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -147.13%
ROE -538.91%
Debt/Equity 0.7
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%-48.07%
EPS 1Y (TTM)4.11%
Revenue 1Y (TTM)-16.46%

ICCM Forecast & Estimates

9 analysts have analysed ICCM and the average price target is 2.64 USD. This implies a price increase of 122% is expected in the next year compared to the current price of 1.19.

For the next year, analysts expect an EPS growth of 29.73% and a revenue growth 50.15% for ICCM


Analysts
Analysts82.22
Price Target2.64 (121.85%)
EPS Next Y29.73%
Revenue Next Year50.15%

ICCM Ownership

Ownership
Inst Owners0.28%
Ins Owners47.49%
Short Float %4.35%
Short Ratio1.33